Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve® devices: Results from the France 2 Registry

Catheterization and Cardiovascular Interventions

Volumn 86, Issue 3, 2015, Pages E158-E166

  Mouillet, Gauthier ^a   Lellouche, Nicolas ^a   Yamamoto, Masanori ^a   Oguri, Atsushi ^a   Dubois Rande, Jean Luc ^a   Van Belle, Eric ^b   Gilard, Martine ^c   Laskar, Marc ^d   Teiger, Emmanuel ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

^d LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

aortic valve stenosis; pacemaker; transcatheter aortic valve implantation

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR MORTALITY; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PACEMAKER IMPLANTATION; PROSPECTIVE STUDY; SELF EXPANDING STENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VERY ELDERLY; CASE REPORT; COMORBIDITY; DEVICES;

AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84939472910     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25818     Document Type: Article

References (25)

1. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ,. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
2. Latsios G, Gerckens U, Grube E,. Transaortic transcatheter aortic valve implantation: A novel approach for the truly "no-access option" patients. Catheter Cardiovasc Interv 2010; 75: 1129-1136.
3. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrie D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyr G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertr B, Van Belle E, Laskar M,. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-1715.
4. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M,. Guidelines for cardiac pacing and cardiac resynchronization therapy: The task force for cardiac pacing and cardiac resynchronization therapy of the european society of cardiology. Developed in collaboration with the european heart rhythm association. Eur Heart J 2007; 28: 2256-2295.
5. Munoz-Garcia AJ, Hernandez-Garcia JM, Jimenez-Navarro MF, Alonso-Briales JH, Rodriguez-Bailon I, Pena-Hernandez J, Fernandez-Pastor J, Dominguez-Franco AJ, Barrera-Cordero A, Alzueta-Rodriguez J, de Teresa Galvan E,. Changes in atrioventricular conduction and predictors of pacemaker need after percutaneous implantation of the CoreValve(R) aortic valve prosthesis. Rev Esp Cardiol 2010; 63: 1444-1451.
6. Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P, Pilgrim T, Gloekler S, Khattab AA, Huber C, Carrel T, Eberle B, Meier B, Boekstegers P, Juni P, Gerckens U, Grube E, Windecker S,. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol 2012; 60: 493-501.
7. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW,. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The siegburg first-in-man study. Circulation 2006; 114: 1616-1624.
8. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R,. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50: 69-76.
9. Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, Garcia-Garcia H, Schultz C, van Domburg R, van Es GA, van Geuns R, de Jaegere P, Serruys PW,. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention 2010; 6: 475-484.
10. Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence MS, Brown S, Khan SQ, Walker N, Trivedi U, Hutchinson N, De Belder AJ, Moat N, Blackman DJ, Levy RD, Manoharan G, Roberts D, Khogali SS, Crean P, Brecker SJ, Baumbach A, Mullen M, Laborde JC, Hildick-Smith D,. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: Incidence and contributing factors (the UK CoreValve collaborative). Circulation 2011; 123: 951-960.
11. Popma JJ., Medtronic's CoreValve US Pivotal Trial Results Presented at TCT. 2013. JACC 2013; 62 Issue 18, Supplement 1.
12. Erkapic D, Kim WK, Weber M, Mollmann H, Berkowitsch A, Zaltsberg S, Pajitnev DJ, Rixe J, Neumann T, Kuniss M, Sperzel J, Hamm CW, Pitschner HF,. Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace 2010; 12: 1188-1190.
13. Bleiziffer S, Ruge H, Horer J, Hutter A, Geisbusch S, Brockmann G, Mazzitelli D, Bauernschmitt R, Lange R,. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010; 3: 524-530.
14. Calvi V, Puzzangara E, Pruiti GP, Conti S, Di Grazia A, Ussia GP, Capodanno D, Tamburino C., Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol 2009; 32 Suppl1: S126-130.
15. Baan J,J, Yong ZY, Koch KT, Henriques JP, Bouma BJ, Vis MM, Cocchieri R, Piek JJ, de Mol BA,. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J 2010; 159: 497-503.
16. Jilaihawi H, Chin D, Vasa-Nicotera M, Jeilan M, Spyt T, Ng GA, Bence J, Logtens E, Kovac J,. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 2009; 157: 860-866.
17. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S,. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-607.
18. Tchetche D, Modine T, Farah B, Vahdat O, Sudre A, Koussa M, Lereun C, Nejjari M, Choby M, Rosencher J, Sorbets E, Fajadet J,. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve(R) accutrak system. EuroIntervention 2012; 8: 556-562.
19. Haworth P, Behan M, Khawaja M, Hutchinson N, de Belder A, Trivedi U, Laborde JC, Hildick-Smith D,. Predictors for permanent pacing after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 76: 751-756.
20. Mouillet G, Lellouche N, Lim P, Meguro K, Yamamoto M, Deux JF, Monin JL, Bergoend E, Dubois-Rande JL, Teiger E,. Patients without prolonged QRS after TAVI with CoreValve device do not experience high-degree atrio-ventricular block. Catheter Cardiovasc Interv 2013; 81: 882-887.
21. Sweeney MO, Prinzen FW,. A new paradigm for physiologic ventricular pacing. J Am Coll Cardiol 2006; 47: 282-288.
22. Brenyo A, Goldenberg I, Barsheshet A,. The downside of right ventricular apical pacing. Indian Pacing Electrophysiol J 2012; 12: 102-113.
23. Sundell J, Engblom E, Koistinen J, Ylitalo A, Naum A, Stolen KQ, Kalliokoski R, Nekolla SG, Airaksinen KE, Bax JJ, Knuuti J,. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol 2004; 43: 1027-1033.
24. Vernooy K, Verbeek XA, Peschar M, Crijns HJ, Arts T, Cornelussen RN, Prinzen FW,. Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Eur Heart J 2005; 26: 91-98.
25. van der Boon RM, Houthuizen P, Nuis RJ, van Mieghem NM, Prinzen F, de Jaegere PP., Clinical implications of conduction abnormalities and arrhythmias after transcatheter aortic valve implantation. Curr Cardiol Rep 2014; 16: 429.